Interior Banner 6
Interior Banner 9
Interior Banner 1
Interior Banner 7
Interior Banner 2
Interior Banner 3
Interior Banner 4
Interior Banner 5

Press Releases

Hub lab seeks wider cystic fibrosis cure

Dec 3, 2012
Word last week that the U.S. Food and Drug Administration had approved a drug developed by a Cambridge biotech company to treat a rare form of cystic fibrosis that affects about 1,200 people upped the ante for a lab in neighboring Charlestown trying to find a cure for the other 69,000 sufferers of the disease.

“It’s a huge milestone,” Richard Fitzpatrick, chief operating officer of the Flatley Discovery Lab, said of Vertex Pharmaceuticals’ new drug, Kalydeco. “But it will only be effective for roughly 3 to 6 percent of the CF population. Now our job is to find (drugs) that can help the other 95 percent.”

 

Read Full Article Here

News & Developments

Oct 10, 2013 Flatley Discovery Lab, LLC Nominates Clinical Candidate for Treatment of Cystic Fibrosis
CHARLESTOWN, Mass.--(PRESS ENTITY)—October 10, 2013—Flatley Discovery Lab, LLC today announced that it has nominated FDL169, an orally available small molecule for the treatment of Cystic Fibrosis, as a clinical candidate and initiated IND-enabling st
Dec 3, 2012 Hub lab seeks wider cystic fibrosis cure
Word last week that the U.S. Food and Drug Administration had approved a drug developed by a Cambridge biotech company to treat a rare form of cystic fibrosis that affects about 1,200 people upped the ante for a lab in neighboring Charlestown...
Dec 3, 2012 Venture firm backs start-ups targeting cystic fibrosis
John Flatley, a real estate developer and philanthropist, has founded an investment group called Flatley Venture Capital to back life sciences start-ups with potential treatments for the genetic disease cystic fibrosis. Flatley, who has a close relative w
Dec 3, 2012 WHOI teaming with Flatley Discovery Lab in search for effective treatments for cystic fibrosis.
The Woods Hole Oceanographic Institution (WHOI) has signed a $1.18 million agreement with the Flatley Discovery Lab in Charlestown, Mass., to investigate and supply marine microbial extracts as possible treatments for cystic fibrosis (CF).